Thomas Jennings
Operationeel Directeur bij Morphick, Inc.
Profiel
Thomas P.
Jennings is currently the Director at Ausio Pharmaceuticals LLC and the COO, Corporate Secretary & General Counsel at Morphick, Inc. He previously served as the President at PediaMed Pharmaceuticals, Inc. from 2002 to 2007 and as the Secretary & General Counsel at Xanodyne Pharmaceuticals, Inc. He was also the President at Union Springs LLC from 1999 to 2007.
Jennings holds a graduate degree from Northern Kentucky University and an undergraduate degree from the University of Cincinnati (Ohio).
Actieve functies van Thomas Jennings
Bedrijven | Functie | Begin |
---|---|---|
Ausio Pharmaceuticals LLC
Ausio Pharmaceuticals LLC BiotechnologyHealth Technology Ausio Pharmaceuticals LLC develops pharmaceutical products for the aging population. It offers AUS-131, a nonsteroidal, nonhormonal estrogen receptor ß (ERß) agonist that offers a potentially safer alternative to estrogen for the treatment of menopausal symptoms. The company was founded in 2006 and is headquartered in Cincinnati, OH. | Directeur/Bestuurslid | - |
Morphick, Inc.
Morphick, Inc. Packaged SoftwareTechnology Services Morphick, Inc. provides cyber security managed detection and response services. It offers professional services such as incident response, compromise assessment, threat hunting and malware and security defense assessment. The company was founded by Paul Fry, Michael Picton, Brian Klenke and Brian Minick in 2015 and is headquartered in Cincinnati, OH. | Operationeel Directeur | - |
Eerdere bekende functies van Thomas Jennings
Bedrijven | Functie | Einde |
---|---|---|
PediaMed Pharmaceuticals, Inc.
PediaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PediaMed Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company provides medicine in therapeutic categories, including respiratory and allergy, infectious disease, gastroenterology, and central nervous systems. The company was founded in 1999 and is headquartered in Florence, KY. | President | 01-03-2007 |
Union Springs LLC
Union Springs LLC Investment ManagersFinance Union Springs LLC (Union Springs) is a venture capital firm founded in 1998 by Roger D. Griggs. The firm is headquartered in Fort Mitchell, Kentucky. | President | 01-03-2007 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Algemeen Adviseur | - |
Opleiding van Thomas Jennings
University of Cincinnati (Ohio) | Undergraduate Degree |
Northern Kentucky University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
PediaMed Pharmaceuticals, Inc.
PediaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PediaMed Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company provides medicine in therapeutic categories, including respiratory and allergy, infectious disease, gastroenterology, and central nervous systems. The company was founded in 1999 and is headquartered in Florence, KY. | Health Technology |
Union Springs LLC
Union Springs LLC Investment ManagersFinance Union Springs LLC (Union Springs) is a venture capital firm founded in 1998 by Roger D. Griggs. The firm is headquartered in Fort Mitchell, Kentucky. | Finance |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Health Technology |
Ausio Pharmaceuticals LLC
Ausio Pharmaceuticals LLC BiotechnologyHealth Technology Ausio Pharmaceuticals LLC develops pharmaceutical products for the aging population. It offers AUS-131, a nonsteroidal, nonhormonal estrogen receptor ß (ERß) agonist that offers a potentially safer alternative to estrogen for the treatment of menopausal symptoms. The company was founded in 2006 and is headquartered in Cincinnati, OH. | Health Technology |
Morphick, Inc.
Morphick, Inc. Packaged SoftwareTechnology Services Morphick, Inc. provides cyber security managed detection and response services. It offers professional services such as incident response, compromise assessment, threat hunting and malware and security defense assessment. The company was founded by Paul Fry, Michael Picton, Brian Klenke and Brian Minick in 2015 and is headquartered in Cincinnati, OH. | Technology Services |